Engineering Regeneration

Clinical biomaterials
for tissue repair

Pioneering advanced therapeutics for trauma care, cardiac repair, bone defects, wound care, nerve regeneration, liver fibrosis, and IBD.

8+

Product Programs

6

Clinical Areas

25+

Publications

Pipeline 1/8
TRL 5-6

Cardiac Repair

CardioHeal

Injectable hydrogel for post-MI regeneration.

GLP

Trauma Care

Cryo-HaemoClot

Instant shape-memory blood clotting matrix.

TRL 4-5

Bone Defects

OsteoCarrier

Nanotechnology-based bone void filler for accelerated osteogenesis and repair.

Regulatory

Liver Fibrosis

HepatoRegen

BioNano spray for localized liver fibrosis therapy and tissue regeneration.

Preclinical

Electroceuticals

ElectroGel

Conductive biomaterial platform for responsive tissue stimulation.

Regulatory

IBD

ColoRegen

Thermo-responsive localized JAK inhibitor therapy for mucosal healing.

Preclinical

Chronic Wounds

OxOBand

Antioxidant and oxygen releasing regenerative dressing for chronic wounds.

Patent

Antiseptic Care

DermaHeal

Sustained iodine-release wound matrix for infected chronic wounds.

Discover Our Story
01

Who We Are

Bridging the gap between
advanced science
and clinical translation.

Founded in 2022 by tissue engineering experts, Regenmedica develops cutting-edge polymeric and ceramic biomaterials specifically engineered for complex tissue repair and recovery.

Our story began within the advanced laboratories of IIT Kanpur, where decades of research repeatedly highlighted a painful reality: the most transformative biomaterials were failing to reach the patients who needed them most.

Today, our mission is to break that barrier. We translate high-impact scientific research into accessible, indigenous healthcare solutions, committed to solving critical unmet clinical needs globally.

ResearchTranslationAccess
01.

Tissue Engineering

Deep foundational knowledge in cellular mechanics, utilizing ADSC-derived exosomes and localized delivery systems to promote true regeneration rather than mere symptomatic relief.

02.

Polymeric & Ceramic

Proprietary synthesis of shape-memory cryogels, nanohydroxyapatite composites, and thermo-responsive copolymers forming the backbone of our therapeutics.

03.

Indigenous Care

Scalable, highly effective interventions manufactured under GLP conditions to provide state-of-the-art care at accessible price points for global markets.

Prof. Ashok Kumar

Prof. Ashok Kumar

Founder & Director - RegenMedica

"True medical innovation is measured not by publications, but by its presence in the operating room."

The 'valley of death' in deep-tech healthcare claims thousands of promising therapies every year. Regenmedica was incorporated specifically to bridge this gap.

We are not just a research outfit; we are a translational engine. Every polymer we synthesize and every composite we formulate is designed from day one with GLP scalability, ISO compliance, and surgical utility in mind.

Prof. Ashok Kumar

Founder & Director

Dept. of BSBE, IIT Kanpur

15+

Patents Filed

CTRI

Trial Approvals

ISO

Compliance

GLP

Scaled Facilities

Innovations & Portfolio

Our Product Programs

A diverse pipeline of advanced therapeutics spanning hemostasis, cardiac repair, bone reconstruction, and precision localized treatments.

CardioHeal
Porcine Preclinical Studies

Cardiac Repair

CardioHeal

Post-MI Regeneration

Injectable hydrogel for minimally invasive delivery of exosomes to promote cardiac regeneration.

View Details
ElectroGel
CTRI Approval Granted

Nerve Regeneration

ElectroGel

Bioelectric Implant

Conductive cryogel harnessing electrical stimulation to guide nerve regrowth after paralysis.

View Details
OsteoCarrier
TML + GLP Scale-up

Bone Defects

OsteoCarrier

Nanotech Bone Filler

Injectable bio-composite of nanohydroxyapatite addressing critical defects and osteomyelitis.

View Details
HepatoRegen Spray
Regulatory Approval

Liver Fibrosis

HepatoRegen Spray

BioNano Spray

Bioadhesive formulation infused with exosomes that crosslinks into a hydrogel for targeted liver therapy.

View Details
ColoRegen Hydrogel
Regulatory Approval

IBD Management

ColoRegen Hydrogel

TofaMucoHeal

JAK inhibitor-based rectal therapy utilizing thermo-responsive copolymers for mucosal healing.

View Details
Cryo-HaemoClot
TML + GLP Scale-up

Trauma Care

Cryo-HaemoClot

Tactical Hemostasis

Soft, absorbent shape-memory bandage designed to stop life-threatening bleeding in under 90 seconds.

View Details
OxOBand
Preclinical Regeneration Data

Chronic Wound Care

OxOBand

Oxygen-Releasing Dressing

Antioxidant and oxygen releasing regenerative dressing for diabetic ulcers, burns, pressure ulcers, and chronic wounds.

View Details
DermaHeal
Patented Wound Matrix

Antiseptic Wound Care

DermaHeal

Sustained Iodine Release

Polymeric iodine gel dressing designed for chronic infected wounds with broad-spectrum antiseptic action.

View Details
Core Science

Technology Platforms

Our therapeutics are powered by foundational breakthroughs in advanced materials science, polymer chemistry, and cell biology.

01

Liquid delivery

02

In-situ gel depot

03

Controlled release

Active State

Polymeric Biomaterials

Clinical Pathway

The Regeneration Journey
01
Tissue Damage

Ischemia, trauma, or chronic inflammation disrupts the native matrix.

02
Biomaterial Applied

Localized, minimally invasive delivery of precise therapeutic scaffolds.

03
Cellular Response

Modulation of oxidative stress and targeted bio-signaling (e.g., exosomes).

04
Regeneration

Functional tissue recovery replacing scar formation.

Why It Matters

Designing for
Global Clinical Impact

We focus on indigenous healthcare innovation, ensuring that high-end regenerative therapies are not just theoretically brilliant, but clinically usable, industrially scalable, and economically accessible.

2022

Founded

8

Innovation Programs

2

Core Platforms

Polymeric + Ceramic

7

Clinical Focus Areas

Clinical Usability

Serving surgeons and emergency responders. Our products like NanoCement and Cryo-HaemoClot are designed for single-step, rapid application in high-stress environments without complex preparation.

Industrial Relevance

Serving healthcare systems. We design our synthesis protocols (like our GLP scale-up) for high-yield manufacturing, ensuring supply chain resilience and consistent quality control.

Societal Impact

Serving the global patient population. By innovating indigenous biomaterials, we drastically reduce the cost curve of advanced regenerative treatments, democratizing access to next-generation healthcare.

Partner With Us

Accelerating the
Future of Medicine

We are actively seeking strategic partnerships to advance our pipeline through regulatory pathways and global markets.

Collaboration Opportunities

  • Research & Co-Development
  • Clinical Trial Partnerships
  • Technology Licensing
  • Investment & Funding Rounds
  • Manufacturing & Supply Chain

Direct Inquiries

Prof. Ashok Kumar

ashokkum@iitk.ac.in

ashokastha@gmail.com

Send an Inquiry